Qing Zhang,Lu Wang,Shiqi Wang,Hongxin Cheng,Lin Xu,Gaiqin Pei,Yang Wang,Chenying Fu,Yangfu Jiang,Chengqi He,Quan Wei
Abstract:Abstract Although the treatment of myocardial infarction (MI) has improved considerably, it is still a worldwide disease with high morbidity and high mortality. Whilst there is still a long way to go for discovering ideal treatments, therapeutic strategies committed to cardioprotection and cardiac repair following cardiac ischemia are emerging. Evidence of pathological characteristics in MI illustrates cell signaling pathways that participate in the survival, proliferation, apoptosis, autophagy of cardiomyocytes, endothelial cells, fibroblasts, monocytes, and stem cells. These signaling pathways include the key players in inflammation response, e.g., NLRP3/caspase-1 and TLR4/MyD88/NF-κB; the crucial mediators in oxidative stress and apoptosis, for instance, Notch, Hippo/YAP, RhoA/ROCK, Nrf2/HO-1, and Sonic hedgehog; the controller of myocardial fibrosis such as TGF-β/SMADs and Wnt/β-catenin; and the main regulator of angiogenesis, PI3K/Akt, MAPK, JAK/STAT, Sonic hedgehog, etc. Since signaling pathways play an important role in administering the process of MI, aiming at targeting these aberrant signaling pathways and improving the pathological manifestations in MI is indispensable and promising. Hence, drug therapy, gene therapy, protein therapy, cell therapy, and exosome therapy have been emerging and are known as novel therapies. In this review, we summarize the therapeutic strategies for MI by regulating these associated pathways, which contribute to inhibiting cardiomyocytes death, attenuating inflammation, enhancing angiogenesis, etc. so as to repair and re-functionalize damaged hearts.
What problem does this paper attempt to address?
The paper aims to explore the signaling pathways in myocardial infarction (MI) and their targeted therapeutic strategies. Despite significant improvements in the current treatment methods for myocardial infarction, its high incidence and mortality rates remain a global health issue. The paper points out that after the occurrence of myocardial infarction, processes such as inflammation, fibrosis, and angiogenesis overlap in the damaged myocardium. Cellular signaling pathways play a crucial role in these pathophysiological processes, including the regulation of survival, proliferation, apoptosis, and autophagy of cardiomyocytes, endothelial cells, fibroblasts, monocytes, and stem cells.
The article focuses on several important signaling pathways, such as PI3K/Akt, Notch, TGF-β/SMADs, Wnt/β-catenin, NLRP3/caspase-1, TLR4/MyD88/NF-κB, Nrf2/HO-1, RhoA/ROCK, MAPK, JAK/STAT, Hippo/YAP, and Sonic hedgehog pathways, and analyzes their functions under post-ischemic pathophysiological conditions, suggesting that these signaling pathways are potential targets in myocardial infarction treatment strategies.
Additionally, the paper introduces new therapies targeting these abnormal signaling pathways, such as drug therapy, gene therapy, protein therapy, cell therapy, and exosome therapy. These therapies repair the damaged heart and restore its function by inhibiting cardiomyocyte death, reducing inflammatory responses, and promoting angiogenesis. In summary, this paper reviews various therapeutic strategies to improve the pathological manifestations of myocardial infarction by modulating relevant signaling pathways.